한글목차

세계 핵산 표지 시장의 미래는 병원 및 클리닉 시장과 진단센터 시장에 기회가 있으며, 유망한 것으로 평가되고 있습니다. 세계 핵산 표지 시장 규모는 2025-2031년 CAGR 7.7%로 성장할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 효소 및 유전체 연구에 대한 관심 증가, 맞춤형 치료에 대한 요구 증가, 의료비 증가입니다.

• Lucintel의 예측에 따르면, 표지 유형 카테고리에서 비오틴 기반은 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.
• 최종 용도 부문에서는 진단센터가 예측 기간 동안 높은 성장세를 보일 것으로 예상됩니다.
• 지역별로는 북미가 예측 기간 동안 계속해서 가장 큰 시장을 형성할 것으로 예상됩니다.

핵산 표지 시장의 전략적 성장 기회

핵산 표지 시장은 바이오테크놀러지의 발전과 진단 솔루션에 대한 수요 증가에 힘입어 큰 성장이 예상됩니다. 혁신적인 기술을 활용하여 시장에서의 입지를 강화하고자 하는 기업들에게 전략적 기회가 창출되고 있습니다. 이 글에서는 이러한 변화의 흐름 속에서 5가지 주요 성장 기회를 소개합니다.

• 신흥 시장 진출: 기업들은 동남아시아, 아프리카 등 신흥 시장에서의 핵산 라벨링 솔루션에 대한 수요 증가를 활용할 수 있습니다. 이들 지역에서는 연구 이니셔티브 증가와 의료 인프라의 발전으로 첨단 진단 도구와 표지 기술에 대한 수요가 크게 증가하고 있습니다.
• 개인맞춤형 의료에 대한 투자: 개인맞춤형 의료의 추세는 핵산 표지 기업에게 유리한 기회를 가져다 줍니다. 유전체 프로파일링과 표적치료에 맞는 특수한 표지 시약을 개발함으로써 기업은 정밀의료의 요구에 부응하고, 환자 결과를 개선하며, 시장 수요를 촉진할 수 있습니다.
• 바이오 제약사와의 제휴: 바이오 제약사와의 전략적 파트너십은 핵산 표지 기술의 혁신을 촉진합니다. 공동연구는 첨단 진단 및 치료 솔루션 개발로 이어지며, 각자의 전문성을 활용하여 제품 개발을 가속화하고 시장 경쟁력을 향상시킬 수 있습니다.
• 인공지능 활용: 인공지능(AI)을 핵산 라벨링 프로세스에 통합하는 것은 큰 성장 잠재력을 가지고 있으며, AI는 데이터 분석을 강화하고 라벨링 프로토콜을 최적화하여 정확성과 효율성을 향상시킬 수 있습니다. 이러한 기술 통합은 워크플로우를 간소화하고 더 깊은 통찰력을 얻고자 하는 연구 기관을 끌어들일 수 있습니다.
• 지속 가능한 관행의 중요성: 생명공학 분야에서 지속가능성에 대한 관심이 높아짐에 따라, 환경 친화적 인 표지판 솔루션을 개발할 수 있는 기회가 증가하고 있습니다. 친환경 기술 및 지속 가능한 재료에 투자함으로써 기업은 환경 친화적인 소비자에게 어필하고 책임감 있는 실천을 추구하는 세계 트렌드에 부합할 수 있습니다.

핵산 표지 시장에는 기술 혁신을 촉진하고 시장 범위를 확대할 수 있는 전략적 성장 기회가 풍부합니다. 신흥 시장, 개인 맞춤형 의료, 공동 연구, AI 통합, 지속가능성에 초점을 맞추면 기업은 역동적이고 진화하는 전망 속에서 성공할 수 있는 위치를 선점할 수 있습니다.

핵산표지 시장 활성화 요인 및 과제

핵산 표지 시장은 기술 발전과 진단 솔루션에 대한 수요 증가에 힘입어 크게 성장하고 있습니다. 다양한 촉진요인이 이러한 성장을 가속하는 한편, 지속적인 성장을 보장하기 위해서는 과제를 극복해야 합니다. 이러한 요인을 이해하는 것은 이 변화하는 환경에서 이해관계자들에게 매우 중요합니다. 다음은 시장이 직면하고 있는 5가지 주요 촉진요인과 3가지 과제입니다.

핵산 표지 시장 성장 촉진요인은 다음과 같습니다:

• 진단 수요 증가: 유전성 질환 및 감염성 질환 증가는 효과적인 진단 도구에 대한 수요를 촉진하고 있습니다. 핵산 표지는 분자진단에서 중요한 역할을 하며, 핵산의 정확한 검출 및 정량화를 통해 환자 치료 및 치료 결과를 개선할 수 있습니다.
• 생명공학의 발전: 차세대 염기서열 분석(NGS)과 크리스퍼(CRISPR) 기술 등 생명공학의 급속한 발전이 핵산 표지 시장을 견인하고 있습니다. 이러한 기술에는 민감도와 특이성을 향상시키는 고급 표지 솔루션이 필요하며, 이는 기술 혁신을 촉진하고 연구개발에 대한 투자를 유도하고 있습니다.
• 개인 맞춤형 의료의 성장: 개인 맞춤형 의료로의 전환은 맞춤형 진단 솔루션에 대한 강력한 수요를 창출하고 있습니다. 핵산 표지는 유전체 프로파일링과 표적 치료에 필수적이며, 의료진이 개별 유전자 프로파일을 기반으로 치료를 맞춤화하여 궁극적으로 환자의 결과를 개선할 수 있도록 합니다.
• 정부 이니셔티브 및 자금 지원: 생명공학 연구 및 헬스케어 이니셔티브에 대한 정부 보조금 증가는 핵산 표지 시장의 중요한 촉진요인입니다. 지원 정책과 보조금은 기술 혁신과 개발을 장려하고 기업이 제품 제공을 확대할 수 있는 견고한 환경을 조성합니다.
• 연구 활동의 활성화: 생명과학 연구, 특히 유전체학 및 분자생물학에 대한 투자 확대가 핵산 표지 기술에 대한 수요를 촉진하고 있습니다. 학계와 연구기관은 실험 역량을 강화하기 위해 첨단 표지 솔루션을 적극적으로 찾고 있으며, 이는 시장 성장을 더욱 촉진하고 있습니다.

핵산 표지 시장의 과제는 다음과 같습니다.

• 규제 과제: 복잡한 규제 프레임워크를 극복하는 것은 핵산 표지 시장의 기업들에게 큰 도전이 될 수 있습니다. 진단 도구 및 표지 시약의 까다로운 승인 절차는 제품 출시를 지연시키고, 기술 혁신을 방해하며, 신기술 시장 진입을 제한할 수 있습니다.
• 경쟁과 시장 포화: 핵산 표지 시장은 경쟁이 심화되고 있으며, 많은 기업들이 시장 점유율을 놓고 경쟁하고 있습니다. 이러한 포화 상태는 가격 압박과 수익률 하락을 초래하고, 중소기업의 경우 제품 차별화와 지속적인 성장 유지가 어려워집니다.
• 기술의 복잡성: 핵산 라벨링 분야의 빠른 기술 발전 속도는 경쟁력을 유지하려는 기업에게 도전이 될 수 있습니다. 최신 기술 혁신에 대응하고 제품이 진화하는 고객 요구에 부응할 수 있도록 하기 위해서는 연구개발에 많은 투자가 필요하기 때문에 일부 기업에게는 장벽이 되고 있습니다.

핵산 표지 시장은 진단 수요의 확대, 생명공학의 발전, 개인 맞춤형 의료의 부상 등 다양한 요인에 의해 주도되고 있습니다. 그러나 기업들은 이러한 역동적인 환경에서 성공하기 위해서는 복잡한 규제와 경쟁 증가와 같은 과제를 극복해야 합니다. 시장 성장 촉진요인과 과제를 이해하는 것은 시장 기회를 활용하고자 하는 이해관계자들에게 필수적입니다.

목차

제1장 주요 요약

제2장 세계의 핵산 표지 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019년-2031년)

• 거시경제 동향(2019년-2024년)과 예측(2025년-2031년)
• 세계의 핵산 표지 시장 동향(2019년-2024년)과 예측(2025년-2031년)
• 세계의 핵산 표지 시장 : 표지 유형별
  • 비오틴 기반
  • 형광
  • 방사성
  • 기타
• 세계의 핵산 표지 시장 : 용도별
  • 마이크로어레이
  • DNA 배열 분석
  • In Situ Hybridization
  • 중합효소 연쇄반응(PCR)
  • 기타
• 세계의 핵산 표지 시장 : 최종 용도별
  • 병원 및 클리닉
  • 진단센터
  • 기타

제4장 시장 동향과 예측 분석 : 지역별(2019년-2031년)

• 세계의 핵산 표지 시장 : 지역별
• 북미의 핵산 표지 시장
• 유럽의 핵산 표지 시장
• 아시아태평양의 핵산 표지 시장
• 기타 지역의 핵산 표지 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 핵산 표지 시장 성장 기회 : 표지 유형별
  • 세계의 핵산 표지 시장 성장 기회 : 용도별
  • 세계의 핵산 표지 시장 성장 기회 : 최종 용도별
  • 세계의 핵산 표지 시장 성장 기회 : 지역별
• 세계 핵산 표지 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 핵산 표지 시장 생산능력 확대
  • 세계 핵산 표지 시장에서의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 주요 기업 개요

• Thermo Fisher Scientific
• New England Biolabs
• PerkinElmer
• F. Hoffmann La-Roche
• General Electric Company
• Merck
• Enzo Biochem
• Promega Corporation
• Vector Laboratories
• Agilent Technologies

영문목차

The future of the global nucleic acid labeling market looks promising with opportunities in the hospital/clinic and diagnostic center markets. The global nucleic acid labeling market is expected to grow with a CAGR of 7.7% from 2025 to 2031. The major drivers for this market are the growing interest in enzyme & genomic research, increasing requirements for customized treatment, and rising medical expenditures.

• Lucintel forecasts that, within the label type category, biotin-based is expected to witness the highest growth over the forecast period.
• Within the end-use category, diagnostic center is expected to witness higher growth over the forecast period.
• In terms of regions, North America will remain the largest region over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Nucleic Acid Labeling Market

The nucleic acid labeling market is evolving rapidly, influenced by advancements in biotechnology and the growing demand for precision diagnostics. These trends are reshaping research methodologies and clinical applications, driving innovation in labeling techniques. Below are five key emerging trends that are making an impact in this field.

• Increased Automation: Automation is transforming nucleic acid labeling processes, enhancing efficiency and reducing human error. High-throughput systems enable researchers to perform large-scale experiments with consistent results, significantly expediting the workflow in genomics and diagnostics. This shift is particularly beneficial in clinical laboratories where time-sensitive results are crucial.
• Integration with Next-Generation Sequencing: The integration of nucleic acid labeling with next-generation sequencing (NGS) technologies is on the rise. Advanced labeling methods improve the accuracy and sensitivity of NGS applications, enabling comprehensive genomic analyses. This trend supports personalized medicine initiatives by allowing for more precise detection of genetic variations and mutations.
• Focus on Multiplexing: Multiplexing capabilities are becoming increasingly important in nucleic acid labeling. Researchers are seeking methods that allow simultaneous detection of multiple targets in a single assay, enhancing efficiency and cost-effectiveness. This trend is particularly beneficial for applications in diagnostics and disease monitoring, where rapid results are essential.
• Development of Novel Labels: The market is witnessing the emergence of innovative labeling agents, such as fluorescent dyes and nanoparticles. These novel labels offer improved sensitivity and stability compared to traditional options, facilitating better visualization and analysis of nucleic acids. Their versatility is expanding their use in a wide range of applications, including research, diagnostics, and therapeutics.
• Sustainability Initiatives: There is a growing emphasis on sustainability within the nucleic acid labeling market. Companies are increasingly developing eco-friendly labeling solutions that reduce waste and environmental impact. This trend reflects broader societal shifts toward sustainable practices in biotechnology and is attracting attention from environmentally conscious researchers and organizations.

The nucleic acid labeling market is experiencing transformative changes driven by automation, integration with advanced technologies, and a focus on sustainability. These trends not only enhance research capabilities but also pave the way for innovative diagnostic solutions, ultimately improving patient outcomes and advancing the field of biotechnology.

Recent Developments in the Nucleic Acid Labeling Market

The nucleic acid labeling market is rapidly evolving, marked by significant technological advancements and strategic collaborations. These developments are enhancing the capabilities of researchers and clinicians, paving the way for improved diagnostic tools and therapeutic applications. Below are five recent developments that are shaping the landscape of this dynamic market.

• Launch of Innovative Labeling Kits: Leading companies, such as Thermo Fisher Scientific, have introduced new labeling kits that enhance sensitivity and specificity in nucleic acid detection. These kits utilize cutting-edge technologies, enabling researchers to streamline their workflows and achieve more accurate results in both clinical and research settings.
• Advancements in CRISPR Technology: Recent breakthroughs in CRISPR technology have spurred demand for specialized nucleic acid labeling solutions. Companies are developing novel labels that facilitate precise gene editing and monitoring, thereby supporting advances in genomic research and therapeutic applications. This development is crucial for personalized medicine and targeted therapies.
• Collaborations in R&D: Increased partnerships between academic institutions and biotechnology firms are driving innovation in nucleic acid labeling. Collaborative efforts are focusing on developing advanced labeling techniques and improving existing methodologies. This trend is fostering knowledge exchange and accelerating the commercialization of new products that meet industry needs.
• Regulatory Approvals for Diagnostic Tools: Recent changes in regulatory frameworks have streamlined the approval processes for nucleic acid-based diagnostic tools. These changes facilitate faster market entry for innovative labeling technologies, promoting the development of rapid and reliable diagnostics. This is particularly important in response to global health challenges, such as pandemics.
• Emergence of Eco-Friendly Solutions: A growing number of companies are focusing on developing sustainable nucleic acid labeling products. Innovations in biodegradable materials and greener production processes are gaining traction, addressing environmental concerns in biotechnology. This shift towards sustainability is attracting interest from researchers and organizations committed to responsible practices.

Recent developments in the nucleic acid labeling market are driving significant progress across various sectors, from research to diagnostics. Innovations in technology, collaborations, and a focus on sustainability are shaping the future of this market, ultimately enhancing our understanding of genetics and improving healthcare outcomes.

Strategic Growth Opportunities for Nucleic Acid Labeling Market

The nucleic acid labeling market is poised for significant growth, driven by advancements in biotechnology and an increasing demand for diagnostic solutions. Strategic opportunities are emerging as organizations seek to leverage innovative technologies and expand their market presence. Here are five key growth opportunities in this evolving landscape.

• Expansion into Emerging Markets: Companies can capitalize on the growing demand for nucleic acid labeling solutions in emerging markets, such as Southeast Asia and Africa. These regions are experiencing a rise in research initiatives and healthcare infrastructure improvements, creating a significant need for advanced diagnostic tools and labeling technologies.
• Investment in Personalized Medicine: The trend toward personalized medicine presents a lucrative opportunity for nucleic acid labeling companies. By developing specialized labeling reagents tailored for genomic profiling and targeted therapies, organizations can meet the needs of precision medicine initiatives, enhancing patient outcomes and driving market demand.
• Collaboration with Biopharmaceutical Companies: Strategic partnerships with biopharmaceutical firms can enhance innovation in nucleic acid labeling technologies. Collaborations can lead to the development of advanced diagnostic and therapeutic solutions, leveraging each party's expertise to accelerate product development and improve market competitiveness.
• Utilization of Artificial Intelligence: Integrating artificial intelligence (AI) into nucleic acid labeling processes offers significant potential for growth. AI can enhance data analysis and optimize labeling protocols, leading to improved accuracy and efficiency. This technological integration can attract research institutions looking to streamline their workflows and gain deeper insights.
• Focus on Sustainable Practices: There is a growing emphasis on sustainability in the biotechnology sector, presenting an opportunity for companies to develop eco-friendly labeling solutions. By investing in green technologies and sustainable materials, organizations can appeal to environmentally conscious consumers and align with global trends toward responsible practices.

The nucleic acid labeling market is ripe with strategic growth opportunities that can drive innovation and expand market reach. By focusing on emerging markets, personalized medicine, collaborations, AI integration, and sustainability, companies can position themselves for success in this dynamic and evolving landscape.

Nucleic Acid Labeling Market Driver and Challenges

The nucleic acid labeling market is experiencing significant growth fueled by technological advancements and increasing demand for diagnostic solutions. Various drivers are propelling this growth, while challenges must be navigated to ensure sustained progress. Understanding these factors is crucial for stakeholders in this evolving landscape. Below are five key drivers and three challenges facing the market.

The factors responsible for driving the nucleic acid labeling market include:

• Increasing Demand for Diagnostics: The rising prevalence of genetic disorders and infectious diseases is driving demand for effective diagnostic tools. Nucleic acid labeling plays a critical role in molecular diagnostics, enabling accurate detection and quantification of nucleic acids, which enhances patient care and treatment outcomes.
• Advancements in Biotechnology: Rapid advancements in biotechnology, such as next-generation sequencing (NGS) and CRISPR technology, are propelling the nucleic acid labeling market. These technologies require sophisticated labeling solutions that improve sensitivity and specificity, driving innovation and attracting investment in research and development.
• Growth of Personalized Medicine: The shift towards personalized medicine is creating a strong demand for tailored diagnostic solutions. Nucleic acid labeling is essential for genomic profiling and targeted therapies, allowing healthcare providers to customize treatments based on individual genetic profiles, ultimately improving patient outcomes.
• Government Initiatives and Funding: Increased government funding for biotechnology research and healthcare initiatives is a significant driver in the nucleic acid labeling market. Supportive policies and grants encourage innovation and development, fostering a robust environment for companies to expand their product offerings.
• Rising Research Activities: Growing investment in life sciences research, particularly in genomics and molecular biology, is fueling demand for nucleic acid labeling technologies. Academic institutions and research organizations are actively seeking advanced labeling solutions to enhance their experimental capabilities, further driving market growth.

Challenges in the nucleic acid labeling market are:

• Regulatory Challenges: Navigating complex regulatory frameworks can pose significant challenges for companies in the nucleic acid labeling market. Stringent approval processes for diagnostic tools and labeling reagents may delay product launches, hindering innovation and limiting market access for emerging technologies.
• Competition and Market Saturation: The nucleic acid labeling market is becoming increasingly competitive, with numerous players vying for market share. This saturation can lead to pricing pressures and reduced profit margins, making it difficult for smaller companies to differentiate their offerings and maintain sustainable growth.
• Technological Complexity: The rapid pace of technological advancement in nucleic acid labeling presents challenges for companies seeking to stay competitive. Keeping up with the latest innovations and ensuring that products meet evolving customer needs requires significant investment in research and development, posing a barrier for some organizations.

The nucleic acid labeling market is driven by various factors, including growing demand for diagnostics, advancements in biotechnology, and the rise of personalized medicine. However, companies must also navigate challenges such as regulatory complexities and increased competition to thrive in this dynamic landscape. Understanding these drivers and challenges will be essential for stakeholders looking to capitalize on market opportunities.

List of Nucleic Acid Labeling Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies nucleic acid labeling companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nucleic acid labeling companies profiled in this report include-

• Thermo Fisher Scientific
• New England Biolabs
• PerkinElmer
• F. Hoffmann La-Roche
• General Electric Company
• Merck
• Enzo Biochem
• Promega Corporation
• Vector Laboratories
• Agilent Technologies

Nucleic Acid Labeling by Segment

The study includes a forecast for the global nucleic acid labeling market by label type, application, end use, and region.

Nucleic Acid Labeling Market by Label Type [Analysis by Value from 2019 to 2031]:

• Biotin-Based
• Fluorescent
• Radioactive
• Others

Nucleic Acid Labeling Market by Application [Analysis by Value from 2019 to 2031]:

• Microarray
• DNA Sequencing
• In Situ Hybridization
• Polymerase Chain Reaction
• Others

Nucleic Acid Labeling Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals/Clinics
• Diagnostic Centers
• Others

Nucleic Acid Labeling Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Nucleic Acid Labeling Market

The nucleic acid labeling market has experienced significant growth and innovation, driven by advancements in biotechnology, increased research funding, and rising demand for diagnostics. Key players are focusing on developing more efficient labeling techniques and expanding their product offerings. This report highlights recent developments in the nucleic acid labeling market across the United States, China, Germany, India, and Japan, showcasing trends and emerging technologies that are shaping the landscape.

• United States: The U.S. market has seen increased investment in gene editing and diagnostics, with companies like Thermo Fisher Scientific launching new labeling kits. Advances in CRISPR technology have also propelled demand for nucleic acid labels in research and clinical applications.
• China: China is rapidly advancing its nucleic acid labeling capabilities, with a surge in domestic production and R&D initiatives. The government's support for biotechnology has led to collaborations between universities and industry, resulting in innovative labeling solutions and enhanced diagnostic tools.
• Germany: Germany continues to be a leader in precision biotechnology, with firms like Roche and Qiagen enhancing their nucleic acid labeling products. Recent regulatory changes are streamlining approval processes for new diagnostic tools, fostering innovation, and improving market access for advanced labeling techniques.
• India: The Indian nucleic acid labeling market is expanding due to a rise in molecular diagnostics and personalized medicine. Local startups are developing cost-effective labeling reagents, while partnerships with international firms are facilitating technology transfer and capacity building in the biotechnology sector.
• Japan: Japan is witnessing a surge in demand for nucleic acid labeling in genomics research, driven by advancements in next-generation sequencing technologies. Major companies are investing in developing innovative labeling solutions, with a focus on improving sensitivity and specificity in diagnostics and therapeutic applications.

Features of the Global Nucleic Acid Labeling Market

Market Size Estimates: Nucleic acid labeling market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Nucleic acid labeling market size by label type, application, end use, and region in terms of value ($B).

Regional Analysis: Nucleic acid labeling market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different label types, applications, end uses, and regions for the nucleic acid labeling market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nucleic acid labeling market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the nucleic acid labeling market by label type (biotin-based, fluorescent, radioactive, and others), application (microarray, DNA sequencing, in situ hybridization, polymerase chain reaction, and others), end use (hospitals/clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nucleic Acid Labeling Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Nucleic Acid Labeling Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Nucleic Acid Labeling Market by Label Type
  • 3.3.1: Biotin-Based
  • 3.3.2: Fluorescent
  • 3.3.3: Radioactive
  • 3.3.4: Others
• 3.4: Global Nucleic Acid Labeling Market by Application
  • 3.4.1: Microarray
  • 3.4.2: DNA Sequencing
  • 3.4.3: In Situ Hybridization
  • 3.4.4: Polymerase Chain Reaction
  • 3.4.5: Others
• 3.5: Global Nucleic Acid Labeling Market by End Use
  • 3.5.1: Hospitals/Clinics
  • 3.5.2: Diagnostic Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Nucleic Acid Labeling Market by Region
• 4.2: North American Nucleic Acid Labeling Market
  • 4.2.1: North American Market by Label Type: Biotin-Based, Fluorescent, Radioactive, and Others
  • 4.2.2: North American Market by End Use: Hospitals/Clinics, Diagnostic Centers, and Others
• 4.3: European Nucleic Acid Labeling Market
  • 4.3.1: European Market by Label Type: Biotin-Based, Fluorescent, Radioactive, and Others
  • 4.3.2: European Market by End Use: Hospitals/Clinics, Diagnostic Centers, and Others
• 4.4: APAC Nucleic Acid Labeling Market
  • 4.4.1: APAC Market by Label Type: Biotin-Based, Fluorescent, Radioactive, and Others
  • 4.4.2: APAC Market by End Use: Hospitals/Clinics, Diagnostic Centers, and Others
• 4.5: ROW Nucleic Acid Labeling Market
  • 4.5.1: ROW Market by Label Type: Biotin-Based, Fluorescent, Radioactive, and Others
  • 4.5.2: ROW Market by End Use: Hospitals/Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Nucleic Acid Labeling Market by Label Type
  • 6.1.2: Growth Opportunities for the Global Nucleic Acid Labeling Market by Application
  • 6.1.3: Growth Opportunities for the Global Nucleic Acid Labeling Market by End Use
  • 6.1.4: Growth Opportunities for the Global Nucleic Acid Labeling Market by Region
• 6.2: Emerging Trends in the Global Nucleic Acid Labeling Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Nucleic Acid Labeling Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nucleic Acid Labeling Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: New England Biolabs
• 7.3: PerkinElmer
• 7.4: F. Hoffmann La-Roche
• 7.5: General Electric Company
• 7.6: Merck
• 7.7: Enzo Biochem
• 7.8: Promega Corporation
• 7.9: Vector Laboratories
• 7.10: Agilent Technologies